[30] In a 2004 study only two-thirds of the participants stated they kept a portfolio[29] and another study in 2005 found a not insignificant minority of interviewees were not recording CPD despite reporting learning activities.[22] In one study, the recently qualified and also those with responsibility Selleck beta-catenin inhibitor for training others kept a portfolio.[23] Another study conducted
mid-decade also found hospital pharmacists reporting more CPD hours per annum compared to community pharmacists but in fact primary care pharmacists conducted slightly more CPD hours than their counterparts working in hospitals.[18] A small-scale survey of branch members in 2007 indicated two-thirds had engaged with CPD,[39] and respondents to the PARN survey mostly (84%) reported keeping a CPD record with around a third indicating they kept 10 or more entries.[41] All nine technicians in a study in 2006 were recording CPD but acknowledged some pharmacy technicians might find CPD challenging[27] and 70% of technicians evaluated selleck kinase inhibitor after a CPPE workshop indicated they had used their learning to create a CPD entry.[38] However, a recently published questionnaire study conducted in Wales found 50% of respondents (n = 473) stated they did not have up-to-date CPD records with 255 not having recorded any CPD in that 6-month period; only one-third had up-to-date CPD records.[37] An additional analysis of the
same data by the authors further revealed that of the 57 registered pharmacist prescribers who had responded, 32 did not have up-to-date CPD records and 8 were not sure if they did.[42] Letters and comments were retrieved from the column of ‘letters’ or ‘broad spectrum’/‘features’ in the PJ, where pharmacy professionals have a wide-reaching forum to express their personal views and commentaries on specific topics relating to the profession in GB. While only one letter was found for 2000 and eight in 2001, the number of letters peaked in 2002 (40) with slightly less in 2003 (30) dropping in 2004 (14) and 2005 (23) before settling again. Three
broad-spectrum articles Amobarbital were also analysed. We deemed these letters and commentaries valuable ‘grey literature’ in particular because the PJ is also one of the major resources that pharmacy professionals receive in relation to CPD. Thematic analysis was used to examine the text of the letters and the results are presented here according to the themes identified. Topics of letters retrieved from the PJ reflect the findings of the current literature review in terms of pharmacy professionals’ perceptions of and engagement in CPD in the last decade. In particular, there was evidence of confusion in terms of the difference between CPD and CE with some contributors stating they were more than happy to accept and undertake CE but not CPD. Some needed guidance on documenting CPD records as well as supportive feedback.